Skip to main content
CStone Pharmaceuticals logo

CStone Pharmaceuticals — Investor Relations & Filings

Ticker · 2616 ISIN · KYG2588M1006 LEI · 300300095A57F80T2461 HKEX Manufacturing
Open in API
Filings indexed 3,378 across all filing types
Latest filing 2019-11-07 Capital/Financing Update
Country KY Cayman Islands
Listing HKEX 2616

About CStone Pharmaceuticals

http://www.cstonepharma.com

CStone Pharmaceuticals is an innovation-driven biopharmaceutical company focused on the research, development, and commercialization of anti-tumor drugs. The company is dedicated to addressing the unmet medical needs of cancer patients globally. Its core therapeutic focus is on innovative immuno-oncology and molecularly targeted therapies. The R&D pipeline is strategically balanced, featuring potential first-in-class or best-in-class assets, including Antibody-Drug Conjugates (ADC) and multi-specific antibodies. CStone has successfully launched four innovative drugs and secured multiple New Drug Application and indication approvals.

Recent filings

Filing Released Lang Actions
VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES PROMISING TRIAL DATA ON ITS ANTI-PD-L1 ANTIBODY IN RR-ENKTL PATIENTS WITH A COMPLETE RESPONSE RATE OF 31.8%
Capital/Financing Update Classification · 85% confidence The document is a voluntary announcement by CStone Pharmaceuticals about promising clinical trial data for their anti-PD-L1 antibody in a specific patient group. It discusses trial design, patient demographics, efficacy, and safety data, and mentions upcoming presentations at a scientific meeting (ASH Annual Meeting). There is no indication that this is a full financial report, audit, earnings release, or regulatory filing. It is not a report publication announcement since it contains substantive data and analysis rather than just announcing a report's release. The content focuses on clinical trial results and company updates rather than financial or governance matters. Therefore, this document is best classified as a Capital/Financing Update (CAP) because it relates to clinical trial progress and data that could impact the company's valuation and financing prospects, and it is a voluntary announcement rather than a regulatory filing or earnings release.
2019-11-07 English
Monthly Returns
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/10/2019 and submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised and issued share capital, share options, warrants, convertibles, and other share-related capital changes. The content focuses on share capital changes and movements in securities rather than financial performance, earnings, or management commentary. It is a regulatory disclosure about share capital movements, consistent with announcements about share issues or capital changes. The document is lengthy (15,000 characters) and contains detailed data on share capital movements, not just a brief announcement or a certification. Therefore, the most appropriate classification is 'Share Issue/Capital Change' (SHA).
2019-11-05 English
DEEMED DISPOSAL OF 18.36% EQUITY INTERESTS OF HAOSHENG COMPANY AND ACQUISITION OF 400 MILLION TONNES OF COAL RESERVES IN SHILAWUSU COAL FIELD
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a discloseable transaction involving a deemed disposal of equity interests and acquisition of coal reserves by Yanzhou Coal Mining Company Limited. It details a capital increase agreement, valuation reports, and compliance with Hong Kong Listing Rules Chapter 14. The content focuses on transaction details, valuation assumptions, and regulatory compliance disclosures. It is not a full financial report, earnings release, or management discussion, but rather a regulatory announcement about a significant transaction subject to reporting requirements under the Hong Kong Listing Rules. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2019-11-04 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2019
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' and details movements in authorized and issued share capital, share options, warrants, convertibles, and other share-related activities for the month ended 31/10/2019. It is addressed to the Hong Kong Exchanges and Clearing Limited and includes confirmations related to share issuance compliance. The content focuses on changes in share capital and securities issued during the month, which aligns with announcements regarding share capital changes rather than a full financial report or earnings release. The document is detailed and lengthy (15,000 characters), indicating it is not a brief announcement but a substantive report on share capital movements. Therefore, the most appropriate classification is 'Share Issue/Capital Change' (SHA).
2019-11-04 English
ANNOUNCEMENT IN RELATION TO THE RESOLUTIONS PASSED AT THE 2019 SECOND EXTRAORDINARY GENERAL MEETING
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an announcement regarding the resolutions passed at the 2019 Second Extraordinary General Meeting (EGM) of Yanzhou Coal Mining Company Limited. It details the convening and attendance of the EGM, the resolutions considered and passed, voting results, presence of scrutineers and lawyers, and the distribution of a special cash dividend. The content focuses on the official results of shareholder votes at a general meeting, including dividend declarations and approval of financial agreements. There is no detailed financial report or analysis, nor is it a presentation or a regulatory filing of a different nature. The document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting outcomes and related shareholder meeting resolutions.
2019-11-01 English
SUPPLEMENTAL ANNOUNCEMENT-CONTINUING CONNECTED TRANSACTION
Capital/Financing Update Classification · 95% confidence The document is an announcement from Yanzhou Coal Mining Company Limited regarding a supplemental announcement about a continuing connected transaction, specifically the maximum transaction amount under a diesel fuel supply agreement for a defined future period. It references a previous announcement dated 25 October 2019 and provides updated financial cap information. The document is relatively short (2356 characters) and does not contain financial statements, detailed financial analysis, or comprehensive report content. It is an update on a specific transaction amount, which fits the category of a Capital/Financing Update (CAP) as it relates to financial transaction limits and agreements. It is not an annual or interim report, audit report, or earnings release, nor is it a regulatory filing or voting announcement. Therefore, the best classification is Capital/Financing Update (CAP).
2019-11-01 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.